Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.765 USD | -0.28% | +0.47% | -42.09% |
May. 10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.09% | 45.33M | |
+40.14% | 723B | |
+34.28% | 595B | |
-3.74% | 369B | |
+20.43% | 332B | |
+3.01% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.33% | 168B |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment